The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats

BACKGROUND: Sarcopenia, the age-related, progressive loss of skeletal muscle mass, strength, and function, is a considerable socioeconomic burden by increasing risks of falls, fractures, and frailty. Moreover, sarcopenic patients are often obese and therapeutic options are very limited. METHODS: Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Pötsch, Mareike S., Tschirner, Anika, Palus, Sandra, von Haehling, Stephan, Doehner, Wolfram, Beadle, John, Coats, Andrew J. S., Anker, Stefan D., Springer, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053568/
https://www.ncbi.nlm.nih.gov/pubmed/24272787
http://dx.doi.org/10.1007/s13539-013-0125-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053568/
https://www.ncbi.nlm.nih.gov/pubmed/24272787
http://dx.doi.org/10.1007/s13539-013-0125-7

Ejemplares similares